A Meeting of the Trust Board of Directors, in Public
To be held on Tuesday 23rd February 2016, starting at 2.00 pm
in the Main Boardroom, Diana Princess of Wales Hospital
For the purpose of transacting the business set out below
1. / Apologies for Absence / Verbal
Dr James Whittingham, Chairman
2. / Chairman’s Remarks / Verbal
Dr James Whittingham, Chairman
3. / Declaration of Interests / Verbal
Dr James Whittingham, Chairman
4. / To Approve the Minutes of the Previous Meeting held on 26th January 2016 / To Follow
Dr James Whittingham, Chairman / NLG(16)058
5. / Matters Arising from the Minutes:
6. / Chief Executive’s Monthly Update for February 2016(20 mins) / Attached
Karen Jackson, Chief Executive / NLG(16)059
7. / Quality and Safety:
7.1Patient Story – (Mrs Stock’s Story)(5 mins) / Verbal
Jo Loughborough, Patient Experience Practitioner
7.2Quality Development and Continuous Improvement Plans:
7.2.1Quality Development Plan and KPI’s(5 mins) / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary / NLG(16)060
7.3Serious Untoward Incidents including ‘Never Events’ (5 mins) / To Follow
Wendy Booth, Director of Performance Assurance & Trust / NLG(16)061
Secretary
7.4Staffing Reports:
7.4.1Staffing Capacity and Capability on our Wards (5 mins) / Attached
Angie Davies, Deputy Chief Nurse / NLG(16)062
Reports from Board Sub Committees:
7.5Quality and Patient Experience Committee (QPEC):
7.5.1QPEC Highlight Report, February 2016 (5 mins) / Verbal
Alan Bell, Non-Executive Director
7.5.2Board Challenge / Verbal
7.6Mortality Performance & Assurance Committee (MPAC):
7.6.1Mortality Performance Assurance Committee Highlight Report, / To Follow
February 2016(5 mins) / NLG(16)063
Dr James Whittingham, Chairman
7.6.2Board Challenge / Verbal
7.7Infection Prevention & Control Committee (IPCC):
7.7.1IPCC Highlight Report, February 2016(5 mins) / Attached
Stan Shreeve, Non-Executive Director / NLG(16)064
7.7.2Board Challenge
7.8Reflection on a Patient Story (10 mins) / Verbal
8. / Strategy and Planning:
8.1Healthy Lives, Healthy Futures Update(10 mins) / Verbal
Karen Jackson, Chief Executive
9. / Compliance Monitoring:
Reports from Board Sub Committees:
9.1Resources Committee:
9.1.1Resources Committee Highlight Report, February 2016 (5 mins) / To Follow
Neil Gammon, Non-Executive Director / NLG(16)065
9.1.2Board Challenge / Verbal
9.2Trust Governance and Assurance Committee (TGAC):
9.2.1TGAC Highlight Report, February 2016 (5 mins) / To Follow
Anne Shaw, Non-Executive Director / NLG(16)066
9.2.3Board Challenge / Verbal
9.3Audit Committee:
9.3.1Audit Committee Highlight Report, February 2016 / Attached
Stan Shreeve, Non-Executive Director / NLG(16)067
9.3.2Board Challenge / Verbal
10. / Items for Approval
10.1Policy on Handling Intellectual Property & Associated Staff Reward / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary (5 mins) / NLG(16)068
10.2 Performance Management Framework(5 mins) / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary / NLG(16)069
10.3Annual Accounts 2015/16 – Delegation of Authority(5 mins) / Attached
Marcus Hassall, Director of Finance / NLG(16)070
11. / Matters to be Included in the Board Briefing for Governors (5 mins) / Verbal
Dr James Whittingham, Chairman
12. / Trust Board Action Log – Public(5 mins) / To Follow
Dr James Whittingham, Chairman / NLG(16)071
13. / Items for Information(5 mins) / Please see
Dr James Whittingham, Chairman / Appendix A
14. / Any Other Business / Verbal
15. / Date and Time of the Next Meeting / Verbal
The next meeting will be held on Tuesday 29th March 2016, in the Lecture Room, Goole & District Hospital – start time to be confirmed.
Note: Members of the public and other stakeholders are asked to note that, whilst meetings of the Trust Board are now held in public, the primary purpose of these meetings is to enable the Trust Board to properly discharge its responsibility and conduct the business of the Trust. The meetings of the Council of Governors is the forum where the Trust Board is held to account and is also therefore the forum where members of the public may attend to ask questions of the Trust Board.
The meeting is expected to close at 5.00 pm.
PROTOCOL FOR CONDUCT OF BOARD BUSINESS
  • In accordance with Standing Order 14.2 (2007), any Director wishing to propose an agenda item should send to follow notice 8 clear days before the meeting to the Chairman, who shall then include this item on the agenda for the meeting. Requests made less than 8 days before a meeting may be included on the agenda at the discretion of the Chairman. Divisional Directors and Managers may also submit agenda items in this way.
  • In accordance with Standing Order 14.3 (2007), urgent business may be raised provided the Director wishing to raise such business has given notice to the Chief Executive not later than the day preceding the meeting or in exceptional circumstances not later than one hour before the meeting.
  • Board members wishing to ask any questions relating to those reports listed under ‘Items for Information’ should raise them with the appropriate Director outside of the Board meeting. If, after speaking to that Director, it is felt that an issue needs to be raised in the Board setting, the appropriate Director should be given advance notice of this intention, in order to enable him/her to arrange for any necessary attendance at the meeting.
NB:When staff attend Board meetings to make presentations (having been advised of the time to arrive by the Board Secretary), it is intended to take their item next after completion of the item then being considered. This will avoid keeping such people waiting for long periods.
A P P E N D I X A
Listed below is a schedule of documents circulated to all Board members for information.
The Board has previously agreed these items do not routinely need to feature for discussion on Board agendas but that any questions arising from these papers should be raised with the responsible Director. If after having done so any Director believes there are matters arising from these documents that warrant discussion within the Board setting, they should contact the Chairman, Chief Executive or Board Administrator, who will include the issue on a future agenda.
13. / Items for Information: / (To note)
Sub-Committee Supporting Papers
QPEC
13.1QPEC Minutes, February 2016 / To Follow
Tara Filby, Chief Nurse / NLG(16)072
13.2Monthly Quality Report, February 2016 / To Follow
Tara Filby, Chief Nurse / NLG(16)073

MPAC

13.3MPAC Minutes, February 2016 / To Follow
Lawrence Roberts, Medical Director / NLG(16)074
13.4Monthly Mortality Report, February 2016 / Attached
Lawrence Roberts, Medical Director / NLG(16)075
Resources Committee
13.5Resources Committee Minutes, January 2016 / To Follow
Dr Karen Dunderdale, Deputy Chief Executive / NLG(16)076
13.6Month 10 Finance Update / To Follow
Marcus Hassall, Director of Finance / NLG(16)077
13.7Draft Finance Plan 2016/17 / Attached
Marcus Hassall, Director of Finance / NLG(16)078
13.82016/17 Budget Setting Update / To Follow
Marcus Hassall, Director of Finance / NLG(16)079
13.9Sustainability Plan Update / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary / NLG(16)080
& Marcus Hassall, Director of Finance
13.10Monthly Staffing Report, February 2016 / Attached
Dr Karen Dunderdale, Deputy Chief Executive & Mrs Jayne Adamson, / NLG(16)081
Interim HR Director
TGAC
13.11TGAC Minutes, February 2016 / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary / NLG(16)082
13.12Performance Compliance Report, January 2016 / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary / NLG(16)083
13.13Complaints Analysis Report: Quarter 3 (October to December 2015) / To Follow
Wendy Booth, Director of Performance Assurance & Trust Secretary / NLG(16)084
IPCC
13.14IPCC Minutes, February 2016 / To Follow
Dr Karen Dunderdale, Deputy Chief Executive / NLG(16)085
13.15Trust Orthopaedic Surgical Site Infection Action Plan / Attached
Dr Karen Dunderdale, Deputy Chief Executive / NLG(16)086
13.16C.Difficile Action Plan / Attached
Dr Karen Dunderdale, Deputy Chief Executive / NLG(16)087
13.17MRSA Action Plan / Attached
Dr Karen Dunderdale, Deputy Chief Executive / NLG(16)088

Page 1 of 5